Journal of The Academy of Clinical Microbiologists

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  26 (2024)
Volume  23 (2021)
Volume  22 (2020)
Volume  21 (2019)
Volume  20 (2018)
Volume  19 (2017)
Volume  18 (2016)
Volume  17 (2015)
Volume  16 (2014)
Volume  15 (2013)
Related articles

VOLUME 18 , ISSUE 2 ( July-December, 2016 ) > List of Articles

Drug Review

Ceftaroline Fosamil: An update

Manju K Nair, Saritha Narayanankutty

Citation Information : Nair MK, Narayanankutty S. Ceftaroline Fosamil: An update. 2016; 18 (2):72-73.

DOI: 10.4103/0972-1282.194923

License: CC BY-NC 4.0

Published Online: 17-08-2024

Copyright Statement:  Copyright © 2016; Wolters Kluwer India Pvt. Ltd.


Abstract
PDF Share
  1. Duplessis C, Crum-Cianflone NF. Ceftaroline: A New cephalosporin with activity against methicillin-resistant Staphylococcus aureus (MRSA). Clin Med Rev Ther 2011;3. pii: A2466.
  2. Laudano JB. Ceftaroline fosamil: A new broad-spectrum cephalosporin. J Antimicrob Chemother 2011;66 Suppl 3:iii11-8.
  3. Kollef MH. New antimicrobial agents for methicillin-resistant Staphylococcus aureus. Crit Care Resusc 2009;11:282-6.
  4. Parish D, Scheinfeld N. Ceftaroline fosamil, a cephalosporin derivative for the potential treatment of MRSA infection. Curr Opin Investig Drugs 2008;9:201-9.
  5. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twentieth Informational Supplement M 100-S20. Wayne, PA, USA: CLSI; 2010.
  6. Shirley DA, Heil EL, Johnson JK. Ceftaroline fosamil: A brief clinical review. Infect Dis Ther 2013;2:95-110.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.